Gut bacteria may be responsible for sight loss in certain inherited eye diseases

OX124 is expected to reverse the effects of synthetic opioids such as fentanyl. Credit: Your Hand Please/Shutterstock.com. Orexo has submitted a new drug application (NDA)

Janssen is seeking FDA approval for the combination therapy of RYBREVANT plus chemotherapy for NSCLC. Credit: user:ekem / commons.wikimedia.org. The Janssen Pharmaceutical Companies of Johnson &

CD­MO ACG Bi­o­log­ics re­ceived an FDA 483 let­ter, pub­lished on the FDA web­site this week, not­ing one of its sites failed to con­duct prop­er in­ves­ti­ga­tions